The Rise of the TROP2-Directed ADCs for Solid Tumors
Antibody-drug conjugate (ADC) is a rapidly expanding class of highly potent anticancer drugs which comprises a mAb conjugated to the cytotoxic payload via a chemical linker. Compared with tranditional drugs, ADCs allow for improved drug delivery and reduced toxicity.
Like this book? You can publish your book online for free in a few
minutes!